The aim of this study is to evaluate the hearing behavior of rheumatoid arthritis (RA) and primary Sjögren syndrome (PSS) patients and compare them with a healthy control group and with each other. A comparative cross-sectional study was performed with a group of 117 female RA patients, a group of 60 female PSS patients, and a 251 female healthy control group. Every subject underwent a series of studies including high-frequency audiometry, speech audiometry, and tympanometry. The high-frequency audiometry measured 250 to 16,000 Hz. The 117 patients with RA and the 60 with PSS were diagnosed according to American College of Rheumatology criteria / ACR 2010, and the validated classification of the American-European Consensus Group. Hearing loss was present in 36.8% of the RA group in 500–3000 Hz, 68.4% in 4000–8000 Hz, and 94.9% in 10,000–16,000 Hz. Hearing loss was present in 60% of the PSS group in 500–3000 Hz, 70% in 4000–8000 Hz, and 100% in 10,000–16,000 Hz. The hearing impairment prevalence of both groups was significantly different (p < 0.05) when compared with the healthy control group. We also compared the hearing thresholds between RA and PSS patients, finding a significant hearing threshold increase in 500–3000 Hz of the PSS group. This study consolidates the association between RA and PSS with hearing impairment. A deeper hearing loss was reported in PSS than in RA patients, demonstrating a greater auditory and speech recognition repercussion.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Vambutas A, Pathak S (2016) AAO: Autoimmune and Autoinflamatory (Disease) in Otology: what is new in immune-mediated hearing loss. Laryngoscope Investig Otolaryngol 1(5):110–115. https://doi.org/10.1002/lio2.28
Suchan M, Kaliarik L, Krempasa S, Koval J (2016) Immune-mediated cochleovestibular disease. Bratisl Med J 117(2):87–90
Kohlert S, Bromwich M (2017) Mobile tablet audiometry in fluctuating autoimmune ear disease. J Otolaryngol—Head Neck Surg 46(1):18. https://doi.org/10.1186/s40463-017-0195-1.
M Rajati, M Saghafi, H Rafatpanah, et al. (2016) Immunology-rheumatology approach to sudden sensorineural hearing loss. Curr Rheumatol Rev
Goodball AF, Siddiq MA (2015) Current understanding of the pathogenesis of autoimmune inner ear disease: a review. Clin Otolaryngol 40(5):412–419. https://doi.org/10.1111/coa.12432
Emamifar A, Bjoerndal K, Hansen IMJ (2016) Is hearing impairment associated with rheumatoid arthritis? a review. Open Rheumatol J 10(1):26–32. https://doi.org/10.2174/1874312901610010026
Mathews J, Rao S, Kumar BN, Phil M (2003) Autoimmune sensorineural hearing loss: is it still a clinical diagnosis? J Laryngol Otol 117(3):212–214. https://doi.org/10.1258/002221503321192548
Hatzopulos S, Amoroso C, Aimoni C, Monaco AL et al (2002) Hearing loss evaluation of Sjögren syndrome using distortion product otoacustic emissions. Acta Otolaryngol 548:20–25
Rodríguez A, Roldán A, Villarreal IM et al (2016) Extended high-frequency audiometry (9,000–20,000 Hz). Usefulness in audiological diagnosis. Acta Otorrinolaringol Esp 67(1):40–44. https://doi.org/10.1016/j.otoeng.2015.02.001
Houshang A, Jalil S, Hossein M et al (2014) Conventional audiometry, extended high-frequency audiometry, and DPOAE for early diagnosis of NIHL. Iran Red Cres Med J 16:1–6
Jerger J (1970) Clinical experience with impedance audiometry. Arch Otolaryngol 92(4):311–324. https://doi.org/10.1001/archotol.1970.04310040005002
Dikici O, Muluk NB, Tosun AK, Ünlüsoy I (2009) Subjective audiological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors affecting hearing levels. Eur Arch Otorhinolaryngol 266(11):1719–1726. https://doi.org/10.1007/s00405-009-0975-y
Ahmadzadeh A, Daraei M, Jalessi M, Peyvandi AA, Amini E, Ranjbar LA, Daneshi A (2017) Hearing status in patients with rheumatoid arthritis. J Laryngol Otol 131(10):895–899. https://doi.org/10.1017/S0022215117001670
Ki-Sik K, Hyun-Sook K (2016) Successful treatment of sensorineural hearing loss in Sjögren’s syndrome with corticosteroid. Korean J Intern Med 31:612–615
Jeong H, Chang Y-S, Baek SY (2016) Evaluation of audiometric test results to determine hearing impairment in patients with rheumatoid arthritis: analysis of data from the Korean National Health and Nutrition Examination Survey. PLoS One 11(10):e0164591. https://doi.org/10.1371/journal.pone.0164591
Murdin L, Patel S, Walmsley J (2008) Hearing difficulties are common in patients with rheumatoid arthritis. Clin Rheumatol 27(5):637–640. https://doi.org/10.1007/s10067-007-0802-z
Yildirim A, Surucu G, Dogan S (2015) Relationship between disease activity and hearing impairment in patients with rheumatoid arthritis compared with controls. Clin Rheumatol 35(2):309–314. https://doi.org/10.1007/s10067-015-3129-1
Lasso de la Vega M, Villarreal IM, Lopez-Moya J (2016) Examination of hearing in a rheumatoid arthritis population: role of extended-high-frequency audiometry in the diagnosis of subclinical involvement. Scientifica 2016:1–7. https://doi.org/10.1155/2016/5713283
García Callejo FJ, Tobías NC, Muñoz N (2007) Deterioro auditivo en pacientes con artritis reumatoide. Acta Otorrinolaringol Esp 58(6):232–238
Pascual-Ramos V, Contreras-Yáñez I, Rivera-Hoyos P (2014) Cumulative disease activity predicts incidental hearing impairment in patients with rheumatoid arthritis (RA). Clin Rheumatol 33(3):315–321. https://doi.org/10.1007/s10067-014-2485-6
Rahne T, Clauß F, Plontke SK (2016) Prevalence of hearing impairment in patients with rheumatoid arthritis, granulomatosis with polyangiitis (GPA, Wegener’s granulomatosis), or systemic lupus erythematosus. Clin Rheumatol. https://doi.org/10.1007/s10067-017-3651-4.
JL Treviño-González, MJ Villegas-González, GE Muñoz-Maldonado (2015) Hipoacusia neurosensorial subclínica en pacientesfemeninas con artritis reumatoide. doi:https://doi.org/10.1016/j.circir.2015.05.026.
Thanooja CV, Augustine AM, Lepcha A, Pulukool S, Tyagi AK, Danda D et al. (2015) Audiological profile in primary Sjögren’s syndrome in a tertiary care setting and its clinical implications. Indian J Otolaryngol Head Neck Surg 1–7
Ziavra N, Politi EN, Kastanioudakis I, Skevas A, Drosos AA (2000) Hearing loss in Sjögren’s syndrome patients. A comparative study. Clin Exp Rheumatol 18(6):725–728
Tumiati B, Casoli P, Parmeggiani A (1997) Hearing loss in the Sjögren syndrome. Ann Intern Med 126(6):450–453. https://doi.org/10.7326/0003-4819-126-6-199703150-00005
Treviño González JL, Riega J, Hinojosa Y (2017) Extended high frequency audiometry as early detection of hearing loss in primary Sjögren syndrome. Clin Rheumatol. https://doi.org/10.1007/s10067-017-3750-2.
Neither the research, nor the authors received any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
About this article
Cite this article
Galarza-Delgado, D.A., Villegas Gonzalez, M.J., Riega Torres, J. et al. Early hearing loss detection in rheumatoid arthritis and primary Sjögren syndrome using extended high frequency audiometry. Clin Rheumatol 37, 367–373 (2018). https://doi.org/10.1007/s10067-017-3959-0
- Extended audiometry
- Hearing loss
- High-frequency audiometry
- Rheumatoid arthritis
- Sjögren syndrome